FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Simon Stacey

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Andreas M Kaufmann; Peter L Stern; Elaine M Rankin; Harald Sommer; Volkmar Nuessler; Achim Schneider; Malcom Adams; Toli S Onon; Thomas Bauknecht; Uwe Wagner; Karlijn Kroon; Julian Hickling; Christopher M Boswell; Simon N Stacey; Henry C Kitchener; Jennifer Gillard; Jantien Wanders; John St Clair Roberts; Heinz Zwierzina
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Emma J Davidson; Michael Brown; Deborah J Burt; Joanna L Parish; Kevin Gaston; Henry C Kitchener; Simon N Stacey; Peter L Stern
Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells.
Y Connolly; E Littler; N Sun; X Chen; P C Huang; Simon N Stacey; John R Arrand
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Simon Stacey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Andreas M Kaufmann; Peter L Stern; Elaine M Rankin; Harald Sommer; Volkmar Nuessler; Achim Schneider; Malcom Adams; Toli S Onon; Thomas Bauknecht; Uwe Wagner; Karlijn Kroon; Julian Hickling; Christopher M Boswell; Simon N Stacey; Henry C Kitchener; Jennifer Gillard; Jantien Wanders; John St Clair Roberts; Heinz Zwierzina
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3676-85.
2001: Emma J Davidson; Michael Brown; Deborah J Burt; Joanna L Parish; Kevin Gaston; Henry C Kitchener; Simon N Stacey; Peter L Stern
Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells.
International journal of cancer. Journal international du cancer 2001;94(6):807-12.
2001: Y Connolly; E Littler; N Sun; X Chen; P C Huang; Simon N Stacey; John R Arrand
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 2001;91(5):692-7.
2000: Peter L Stern; Michael Brown; Simon N Stacey; Henry C Kitchener; Ian N Hampson; E S Abdel-Hady; James V Moore
Natural HPV immunity and vaccination strategies.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;19(1-2):57-66.
2000: Michael Brown; Y Zhang; S Dermine; E A de Wynter; C Hart; Henry C Kitchener; Peter L Stern; M A Skinner; Simon N Stacey
Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.
Gene therapy 2000;7(19):1680-9.
2000: Hetty J Bontkes; Tanja D de Gruijl; AJ van den Muysenberg; René H M Verheijen; MJ Stukart; Chris J L M Meijer; Rik J Scheper; Simon N Stacey; Margaret Duggan-Keen; Peter L Stern; Stephen Man; Leszek K Borysiewicz; Jan M M Walboomers
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
International journal of cancer. Journal international du cancer 2000;88(1):92-8.
2000: Simon N Stacey; D Jordan; A J Williamson; Michael Brown; J H Coote; John R Arrand
Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.
Journal of virology 2000;74(16):7284-97.
1999: Michael Brown; D H Davies; M A Skinner; G Bowen; SJ Hollingsworth; Ghulam J Mufti; John R Arrand; Simon N Stacey
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors.
Cancer gene therapy 1999;6(3):238-45.
1998: Margaret Duggan-Keen; Michael Brown; Simon N Stacey; Peter L Stern
Papillomavirus vaccines.
Frontiers in bioscience : a journal and virtual library 1998;3():D1192-208.
1998: G Di Pasquale; Simon N Stacey
Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation.
Journal of virology 1998;72(10):7916-25.
1997: L Rocha-Zavaleta; D Jordan; S Pepper; G Corbitt; F Clarke; Norman J Maitland; Cyril M Sanders; John R Arrand; Peter L Stern; Simon N Stacey
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.
British journal of cancer 1997;75(8):1144-50.
1996: I Tarpey; Simon N Stacey; A McIndoe; D H Davies
Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs).
Vaccine 1996;14(3):230-6.
1995: Simon N Stacey; D Jordan; P J Snijders; Mike Mackett; J M Walboomers; John R Arrand
Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.
Journal of virology 1995;69(11):7023-31.
1995: H D Birley; C Anthony Hart; Simon N Stacey
Human papillomaviruses and the genital tract: old virus, new developments.
Journal of medical microbiology 1995;43(2):81-4.
1994: J S Bartholomew; Simon N Stacey; B Coles; D J Burt; John R Arrand; Peter L Stern
Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
European journal of immunology 1994;24(12):3175-9.
1994: I Tarpey; Simon N Stacey; Julian Hickling; H D Birley; Adrian Renton; A McIndoe; D H Davies
Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.
Immunology 1994;81(2):222-7.
1994: Simon N Stacey; C Eklund; D Jordan; N K Smith; Peter L Stern; J Dillner; John R Arrand
Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
Oncogene 1994;9(2):635-45.
1994: M A Chambers; Simon N Stacey; John R Arrand; M A Stanley
Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model.
The Journal of general virology 1994;75 ( Pt 1)():165-9.
1993: Simon N Stacey; A Ghosh; J S Bartholomew; R W Tindle; Peter L Stern; Mike Mackett; John R Arrand
Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients.
Journal of medical virology 1993;40(1):14-21.
1993: A K Ghosh; N K Smith; Simon N Stacey; S S Glew; M E Connor; John R Arrand; Peter L Stern
Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
International journal of cancer. Journal international du cancer 1993;53(4):591-6.
1992: Simon N Stacey; J S Bartholomew; A Ghosh; Peter L Stern; Mike Mackett; John R Arrand
Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.
The Journal of general virology 1992;73 ( Pt 9)():2337-45.